Stemline Therapeutics Inc (STML) Return on Assets ROA from the first quarter of 2020 to first quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Stemline Therapeutics Inc  (STML)


Stemline Therapeutics Inc's ROA from the first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Stemline Therapeutics Inc's ROA in the first quarter of 2020?
Stemline Therapeutics Inc recorded a cumulative net loss of $-71 million during 12 months ending in the first quarter of 2020, resulting in a negative return on assets (ROA) of -41.37%.

However, within the Healthcare sector 504 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2020 quarter, so far to 4122, from total ROA ranking in the fourth quarter of 2019 at 4711.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Total Assets Change 25.04 % 194.49 % 144.76 % 28.52 % 26.46 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -71 -77 -86 -92 -94
Return On Assets (TTM) -41.37 % -47.31 % -65.23 % -89.95 % -98.88 %
STML's Total Ranking # 4122 # 4711 # 4413 # 4607 # 4689
Total Assets (TTM) in million 170 187 198 128 136
Seq. Total Assets Change -8.94 % -5.65 % 54.64 % -5.89 % 114.46 %
Seq. Net Income Change - - - - -

STML's 5 Years Annual ROA >> Back to STML Management Effectiveness >> Compare STML ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 213
Sector # 505
Overall # 3979

Return On Assets Statistics
High Average Low
-32.01 %
-55.42 %
-98.88 %
(Mar 31 2014)   (Mar 31 2019)





Financial Statements
Stemline Therapeutics Inc's Assets $ 170 million STML's Balance sheet
Stemline Therapeutics Inc's Income $ -21 million Quarterly STML's Income Statement
STML's Income by Division See STML's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change 193.5 % -5.24 % -1.63 % -30.64 % 62.35 %
Total Assets in million 186 63 67 68 98
Y / Y Net Income Change - - - - -
Net Income in million -77 -85 -68 -38 -37
Annual Return On Assets -41.22 % -133.91 % -101.23 % -56.23 % -37.92 %

STML's 5 Years Annual ROA >> Back to STML Management Effectiveness >> Compare STML ROA to its Competitors



More Return On Assets Ratios
STML's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
STML's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for STML's Competitors
Subscribers only: Roa for Stemline Therapeutics Inc's Suppliers
Subscribers only: Return On Assets for STML's Customers

You may also want to know
STML's Roi STML's Inventory Turnover Ratio STML's Growth Rates STML's Dividend Comparisons
STML's Profitability Ratios STML's Asset Turnover Ratio STML's Dividend Growth
STML's Roe STML's Valuation Ratios STML's Financial Strength Ratios STML's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:09:56+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.